FridayFeb 28, 2025 12:20 pm

Forschungszentrum Jülich Becomes First High-Performance Computing Center to Own a D-Wave Quantum Inc. (NYSE: QBTS) Advantage System

Forschungszentrum Jülich scientists have already leveraged D-Wave's technology for research on protein folding, electron interactions and quantum physics. The Advantage™ system features over 5,000 qubits and 15-way connectivity, advancing quantum optimization research. The quantum system will be linked to JUPITER, Europe’s first exascale supercomputer, potentially enabling novel computational applications. The system will be upgraded to D-Wave’s next-generation Advantage2™ quantum processor when available, which D-Wave expects will deliver doubled coherence time, higher qubit connectivity and 40% improvement in energy scaling. The collaboration is anticipated to take the use of quantum technology to a new level, according to Prof. Kristel Michielsen, head…

Continue Reading

WednesdayFeb 26, 2025 10:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Partner on Buffalo, NY Solar and Battery Project

SolarBank and Viridi are collaborating on a 3.06 MW solar and 1.2 MWh battery energy storage system in Buffalo, New York, repurposing a closed landfill, converting unused land into a source of clean energy. Pending approvals and financing, SolarBank is set to begin construction, while Viridi will provide the battery storage system. Viridi's battery systems include integrated fire suppression and anti-propagation technology to enhance safety. Once operational, the project will function under a community solar model, where residents can subscribe to the project, earning credits on their electricity bills without installing personal solar panels. Disseminated on behalf of SolarBank Corporation…

Continue Reading

TuesdayFeb 25, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline. The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025. Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented…

Continue Reading

MondayFeb 24, 2025 1:00 pm

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment

According to the American Cancer Society, cancer is the second leading cause of death globally. Oncology drugs are a cornerstone of modern cancer treatment. Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments. Cancer continues to be one of the most significant health challenges of our time, with its global impact growing every year. The increasing number of cancer diagnoses and related deaths underscores the urgent need for more effective treatments, including advanced oncology drugs. Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are at the forefront of research and development, offering hope for millions of patients worldwide.…

Continue Reading

MondayFeb 24, 2025 12:15 pm

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports Substantial Revenue, Gross Profit Growth, with Key Developments Painting Positive Outlook

The company’s six-month revenue reached $20.1 million CAD ($14.15 million USD), reflecting steady long-term growth despite seasonal fluctuations. Gross profit margin increased to 29.2%, up from 18.4% in the prior year, signaling improved margins. Assets surged 372% to $185.3 million CAD ($130.47 million USD) during the six month period, following the acquisition of Solar Flow-Through Funds Ltd. Recent $70.3 million CAD ($49.5 million USD) deal with Qcells will drive revenue in upcoming quarters. Share price more than doubled in early February, signaling investor interest. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier…

Continue Reading

SaturdayFeb 22, 2025 10:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Qubits 2025 Conference to Showcase ‘Quantum Realized’ Across Scientific Achievements, Technical Advancements and Commercial Applications

D-Wave’s Qubits 2025 quantum computing user conference will be held in Scottsdale, Arizona, March 31 and April 1, as well as a virtual livestream of the first day’s talks. The event will feature presentations from D-Wave executives, customers and industry thought leaders, highlighting product and technical roadmap updates, scientific advancements, the intersection of quantum and AI, and more. Presentations will showcase how the company’s quantum technology is delivering tangible value today. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first supplier of production-grade quantum computers, announced that its Qubits 2025 quantum computing…

Continue Reading

FridayFeb 21, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Focuses Innovation on Hard-to-Treat Tumors

As cancer numbers grow, Calidi Biotherapeutics is at the forefront of developing novel treatments aimed at improving patient outcomes. Calidi’s platform centers on the use of antitumor virotherapies that selectively infect and kill cancer cells while activating the body’s own immune system to attack the tumor. The company’s therapeutic pipeline targets multiple cancer indications, with a focus on hard-to-treat tumors. Cancer remains a significant global health challenge, with certain types exhibiting particularly high mortality rates. Glioblastoma multiforme (“GBM”), triple-negative breast cancer (“TNBC”), sarcoma and lung cancer are among the most aggressive and deadly forms, necessitating urgent advancements in research and…

Continue Reading

ThursdayFeb 20, 2025 10:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Begins Construction on First Battery Storage Project in Ontario

$25.8 million financing from the Royal Bank of Canada will be used for a 4.99 MW Ontario-based battery energy storage system consisting of two projects, SFF-06 and 903. The projects mark SolarBank’s first foray into energy storage, a market expected to reach $31.2 billion USD by 2029. The project benefits from a 22-year contract with Ontario’s electricity operator, ensuring stable revenue. SolarBank is leveraging government incentives, including a 30% Clean Technology Investment Tax Credit. Anvil Crawler Development Corp. was awarded a $1.85 million contract for civil and electrical work on the project. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ:…

Continue Reading

MondayFeb 10, 2025 10:45 am

D-Wave Quantum Inc.’s (NYSE: QBTS) New Leap Quantum LaunchPad(TM) Program Aims to Accelerate the Adoption of Quantum Computing

D-Wave expects the program to drive increased adoption of quantum computing, enabling organizations to experience firsthand how the technology can improve business outcomes and drive scientific discoveries. Qualifying participants will get a 3-month free trial of D-Wave™ technology and support resources. Resources include access to D-Wave’s Advantage™ production-grade annealing quantum computers, D-Wave’s Leap™ real-time quantum cloud service, and technical expert guidance. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, recently announced the launch of the new Leap Quantum LaunchPad program. Designed to accelerate the deployment of quantum computing applications, the initiative offers access…

Continue Reading

FridayFeb 07, 2025 10:45 am

D-Wave Quantum Inc. (NYSE: QBTS), Carahsoft Joining Forces to Expand Distribution of Quantum Computing Solutions to the Public Sector

Under the terms of the agreement, the two companies will co-market D-Wave’s comprehensive solutions to the public sector through Carahsoft’s reseller network. The partnership aims to support growing public sector interest in annealing quantum computing to address complex optimization problems. Available solutions will include real-time access to D-Wave’s Advantage™ quantum computing systems through D-Wave’s Leap™ quantum cloud service, as well as workforce training programs and specialized support. Quantum and hybrid quantum applications using D-Wave’s technology can address various priorities in sectors such as national defense, intelligence, emergency response and management, energy reliability and resilience, infrastructure optimization and more. D-Wave Quantum…

Continue Reading

Contact us: (512) 354-7000